Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 Street, 30-688, Kraków, Poland.
Simcyp Division, Certara UK Limited, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.
J Pharmacokinet Pharmacodyn. 2021 Jun;48(3):387-399. doi: 10.1007/s10928-021-09744-1. Epub 2021 Mar 5.
The circadian rhythm of cardiac electrophysiology is dependent on many physiological and biochemical factors. Provided, that models describing the circadian patterns of cardiac activity and/or electrophysiology which have been verified to the acceptable level, modeling and simulation can give answers to many of heart chronotherapy questions. The aim of the study was to assess the performance of the circadian models implemented in Cardiac Safety Simulator v 2.2 (Certara, Sheffield, UK) (CSS), as well as investigate the influence ofcircadian rhythms on the simulation results in terms of cardiac safety. The simulations which were run in CSS accounted for inter-individual and intra-individual variability. Firstly, the diurnal variations in QT interval length in a healthy population were simulated accounting for heart rate (HR) circadian changes alone, or with concomitant diurnal variations of plasma ion concentrations. Next, tolterodine was chosen as an exemplary drug for PKPD modelling exercise to assess the role of circadian rhythmicity in the prediction of drug effects on QT interval. The results of the simulations were in line with clinical observations, what can serve as a verification of the circadian models implemented in CSS. Moreover, the results have suggested that the circadian variability of the electrolytes balance is the main factor influencing QT circadian pattern. The fluctuation of ion concentration increases the intra-subject variability of predicted drug-triggered QT corrected for HR (QTc) prolongation effect and, in case of modest drug effect on QTc interval length, allows to capture this effect.
心脏电生理学的昼夜节律依赖于许多生理和生化因素。提供的是,已经验证到可接受水平的描述心脏活动和/或电生理学昼夜节律模式的模型,建模和模拟可以为许多心脏时间治疗问题提供答案。本研究的目的是评估 Cardiac Safety Simulator v 2.2(Certara,Sheffield,英国)(CSS)中实施的昼夜节律模型的性能,并研究昼夜节律对模拟结果在心脏安全性方面的影响。在 CSS 中运行的模拟考虑了个体间和个体内的可变性。首先,单独考虑心率(HR)昼夜变化,或同时考虑血浆离子浓度的昼夜变化,模拟健康人群 QT 间期长度的昼夜变化。接下来,选择托特罗定作为 PKPD 建模的示例药物,以评估昼夜节律性在预测药物对 QT 间期影响中的作用。模拟结果与临床观察一致,这可以作为 CSS 中实施的昼夜节律模型的验证。此外,结果表明,电解质平衡的昼夜变化是影响 QT 昼夜节律模式的主要因素。离子浓度的波动增加了预测药物引起的 QT 校正 HR(QTc)延长效应的个体内可变性,并且在药物对 QTc 间期长度的影响适度的情况下,可以捕获这种效应。